Intelligent Ultrasound Group PLC
LSE:IUG
Intelligent Ultrasound Group PLC
LSE:IUG
Price:
12.875
GBX
Market Closed
Market Cap:
£44.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Intelligent Ultrasound Group PLC
LSE:IUG
|
UK |
|
Maharah for Human Resources Company SJSC
SAU:1831
|
SA |
|
Genesco Inc
NYSE:GCO
|
US |
|
L
|
Landa App LLC
OTC:LNDOS
|
US |
|
T
|
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SGX:T14
|
CN |
Balance Sheet
Balance Sheet Decomposition
Intelligent Ultrasound Group PLC
Intelligent Ultrasound Group PLC
Balance Sheet Decomposition is not available for
Intelligent Ultrasound Group PLC
Intelligent Ultrasound Group PLC
Balance Sheet
Intelligent Ultrasound Group PLC
Intelligent Ultrasound Group PLC
Currency: GBP
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
1
|
2
|
4
|
6
|
2
|
9
|
5
|
7
|
3
|
|
| Cash |
0
|
0
|
0
|
0
|
2
|
9
|
5
|
7
|
3
|
|
| Cash Equivalents |
1
|
2
|
4
|
6
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
6
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
2
|
2
|
2
|
3
|
3
|
3
|
2
|
3
|
|
| Accounts Receivables |
1
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Inventory |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Current Assets |
2
|
4
|
6
|
8
|
11
|
13
|
10
|
12
|
8
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
|
| Intangible Assets |
0
|
4
|
3
|
3
|
2
|
2
|
3
|
3
|
4
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
3
N/A
|
8
+157%
|
10
+28%
|
12
+17%
|
14
+16%
|
16
+16%
|
14
-13%
|
16
+16%
|
14
-14%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
0
|
3
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
3
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
3
+241%
|
3
-4%
|
2
-14%
|
3
+3%
|
3
+24%
|
4
+28%
|
4
-5%
|
4
+5%
|
|
| Equity | ||||||||||
| Common Stock |
0
|
0
|
1
|
2
|
2
|
3
|
3
|
3
|
3
|
|
| Retained Earnings |
2
|
3
|
6
|
9
|
13
|
16
|
19
|
21
|
24
|
|
| Additional Paid In Capital |
4
|
7
|
12
|
16
|
22
|
26
|
26
|
30
|
30
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2
N/A
|
5
+123%
|
7
+48%
|
9
+30%
|
11
+20%
|
13
+14%
|
10
-23%
|
12
+25%
|
10
-20%
|
|
| Total Liabilities & Equity |
3
N/A
|
8
+157%
|
10
+28%
|
12
+17%
|
14
+16%
|
16
+16%
|
14
-13%
|
16
+16%
|
14
-14%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
20
|
32
|
91
|
157
|
220
|
269
|
271
|
327
|
327
|
|
Switch to:
Switch to:
See Also
Discover More
